Atria Wealth Solutions’s Eastman Chemical EMN Stock Holding History

Atria Wealth Solutions’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,424	Closed	-$1.41M	–	1917
2024 Q4	$1.41M	Buy	+15,424	New	+$1.58M	0.02%	787
2024 Q1	–	Sell	-3,452	Closed	-$310K	–	1988
2023 Q4	$310K	Buy	3,452 +151	+5%	+$12K	﹤0.01%	1477
2023 Q3	$253K	Buy	+3,301	New	+$274K	﹤0.01%	1526
2022 Q4	–	Sell	-6,144	Closed	-$437K	–	1814
2022 Q3	$437K	Buy	6,144 +1,697	+38%	+$153K	0.01%	1097
2022 Q2	$402K	Sell	4,447 -306	-6%	-$31.7K	0.01%	1070
2022 Q1	$536K	Buy	+4,753	New	+$557K	0.01%	1029

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Atria Wealth Solutions's EMN Position: Q1 2025 in Review

Atria Wealth Solutions sold out of Eastman Chemical (EMN) in Q1 2025, closing a stake of 15,424 shares — an estimated $1.41M sold.

Atria Wealth Solutions first reported a position in EMN in Q1 2022 and held it in 6 quarters. The position peaked at $1.41M in Q4 2024. 808 funds tracked by Wall St. Rank hold EMN as of Q1 2025.

Atria Wealth Solutions reported no remaining Eastman Chemical position as of Q1 2025 after selling out during the quarter.
Atria Wealth Solutions sold 15,424 Eastman Chemical shares in Q1 2025, an estimated $1.41M.
Atria Wealth Solutions first reported a position in Eastman Chemical in Q1 2022 and held it in 6 quarters.
Atria Wealth Solutions's Eastman Chemical position peaked at $1.41M in Q4 2024.
808 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2025.

Based on Atria Wealth Solutions's 13F filing for Q1 2025, filed 9 May 2025.